Homeodomain-Interacting Protein Kinase (HIPk): A Promising Drug Target and Biomarker

Target Name: Homeodomain-interacting protein kinase

NCBI ID: P46788

Homeodomain-interacting protein kinase

Other Name(s): HIPk | HIPK

Homeodomain-Interacting Protein Kinase (HIPk): A Promising Drug Target and Biomarker

Introduction

Homeodomain-interacting protein kinase (HIPk) is a protein that plays a crucial role in various cellular processes, including cell signaling, DNA repair, and metabolism. HIPk is a member of the protein kinase superfamily and is characterized by the presence of a catalytic domain and a unique N-terminal region that contains a domain with homology to DNA-binding proteins, such as histone (HBP), histone modifier (HOM), transcription factor binding domain (TFBD) and nucleic acid binding domain (NBD). The HIPk family includes 11 different isoforms, among which HIPk, HIPk2 and HIPk3 are the most functionally important. They play an important role in a variety of cancers and are highly valuable in drug development. This article will introduce the structure, function, mechanism of action and drug targets of HIPk, and discuss the potential and research status of HIPk as a drug target or biomarker.

Structure and function

HIPk is a 260 amino acid protein with a molecular weight of 31.9 kDa. The active form of HIPk that functions within cells is the phosphorylated form. Phosphorylation can provide the energy required for HIPk enzymatic activity and allow it to bind to the substrate, thereby activating the enzymatic activity of the substrate. Phosphorylation of HIPk is usually mediated by multiple substrate-dependent phosphorylases (PDPs).

The function of HIPk is closely related to histone modifiers, DNA binding and phosphorylation-related proteins (HBPs). HBP is a histone variant that has binding sites to histones. HIPk recruits histones to its active center by phosphorylating HBP, thereby enhancing the binding ability of histones to DNA. In addition, the phosphorylation of HBP can also affect the phosphorylation status of HIPk, thus affecting its enzymatic activity.

Another function of HIPk is to bind to transcription factors. HIPk can bind to a variety of transcription factors, such as RNA polymerase (RNA-pro), and participate in the regulation of gene expression. By binding to transcription factors, HIPk can regulate gene expression levels, thereby playing a key role in cell proliferation, differentiation and tumorigenesis.

In addition, HIPk also has metabolic regulatory functions. HIPk can phosphorylate substrates such as glucose, fatty acids, and amino acids. These metabolic regulatory functions are essential for maintaining cellular homeostasis and organismal growth and development.

Mechanism

The mechanism of action of HIPk mainly involves two aspects: phosphorylation and binding to transcription factors.

1. Phosphorylation mechanism
Phosphorylation of HIPk is usually mediated by PDP. When HIPk binds to its substrate, a substrate-binding enzyme catalyzes the binding of the substrate to the PDP in HIPk. This binding forms a complex that exposes the active center of HIPk, allowing it to bind more tightly to its substrate. In addition, phosphorylation of HIPk can also affect the phosphorylation state of the substrate, thereby affecting its enzymatic activity.

2. Transcription factor binding mechanism
HIPk can bind to a variety of transcription factors, such as RNA polymerase (RNA-pro), and participate in the regulation of gene expression. This binding is usually mediated by the active center of HIPk and the binding protein (HBP) of the transcription factor. HBP is a histone variant that has binding sites to histones. HIPk recruits histones to its active center by phosphorylating HBP, thereby enhancing the binding ability of histones to DNA.

drug target

HIPk plays an important role in a variety of cancers and is therefore considered a potential drug target. The drug targets of HIPk mainly include the following aspects:

1. Anti-tumor drugs
HIPk is an important drug target because the phosphorylation activity of HIPk has an important impact on the sensitivity of various anti-tumor drugs. Research has found that HIP

Protein Name: Homeodomain-interacting Protein Kinase (nonspecified Subtype)

The "Homeodomain-interacting protein kinase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Homeodomain-interacting protein kinase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets